1. TXG will participate in BofA Securities Healthcare Conference on May 13. 2. Live webcast of the event available for public access. 3. 10x Genomics focuses on single cell technology and biological studies. 4. Their solutions support research in oncology, immunology, and neuroscience. 5. Company utilizes various communication channels for information disclosure.
Management's engagement in a healthcare conference can boost investor confidence and visibility. Historical examples show similar events often correlate with positive stock performance due to heightened interest and potential partnerships.
The conference presence indicates confidence and strategic outreach, crucial for investor perceptions. Events like this can significantly enhance market interest in TXG’s innovations.
The upcoming conference offers immediate engagement, likely impacting short-term market sentiment. Companies often see rapid reactions to conference announcements and presentations.
PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference on Tuesday, May 13, at 11:20 a.m. Pacific Time.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Investors: investor@email.com
Media: media@email.com
SOURCE 10x Genomics, Inc.